Maresca, Kevin P. https://orcid.org/0000-0003-4420-1296
Chen, Jianqing
Mathur, Divya
Giddabasappa, Anand
Root, Adam
Narula, Jatin
King, Lindsay
Schaer, David
Golas, Jonathan
Kobylarz, Keith
Rosfjord, Edward
Keliher, Edmund
Chen, Laigao
Ram, Sripad
Pickering, Eve H.
Hardwick, James S.
Rejto, Paul A.
Hussein, Amira
Ilovich, Ohad
Staton, Kevin
Wilson, Ian
McCarthy, Timothy J.
Article History
Received: 5 March 2021
Revised: 19 May 2021
Accepted: 3 June 2021
First Online: 18 June 2021
Declarations
:
: This study was conducted in full compliance with the Invicro Institutional Animal Care and Use Committee (IACUC) policies and procedures, which follow the recommendations of The Guide for the Care and Use of Laboratory Animals (“The Guide,” Institute of Laboratory Animal Resources, National Academy Press, Washington, D.C., 8th Edition, 2011). Invicro’s animal program is accredited by AAALAC International and has an Animal Welfare Assurance statement from the National Institutes of Health (NIH) Office of Laboratory Animal Welfare (OLAW Assurance).
: KPM, JC, DM, AG, JN, LK, DS, JG, KK, ER, EK, LC, SR, EHP, JSH, PAR, and TJM are/were employees of Pfizer, Inc., AH and OI are employees of Invicro, and IAW is an employee of ImaginAb, Inc.